Gene Therapy: A Progress Report 

Blood diseases and neurodegenerative disorders--all have been treated successfully in the last few months with new therapies.

Many have been developed in Philadelphia. 

What is the biological basis for these procedures? 
Are they truly revolutionary?
Are there any ethical considerations?

How can a layperson understand the way these methods work and whether they are the major breakthroughs they claim to be?

FitC member Jerry Kreider, a retired microbiologist professor,  will explain at a layperson level how the new treatments work.

Professor Kreider's presentation on immunotherapy is scheduled for Jan. 16; to register for the immunotherapy program,  please click here .